NTC srl: NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market.

MILAN, Dec. 15, 2021 /PRNewswire/ -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management

Related Keywords

Italy ,Montreal ,Quebec ,Canada ,Milan ,Lombardia ,United States ,America ,Canadian ,Kostenloser Wertpapierhandel ,Riccardo Carbucicchio ,Philipp Binder ,Drug Administration ,Pharma Inc ,I Med Pharma ,North America ,United Statesa ,Chief Operations Officer ,Meibomian Gland ,Pharma ,Form ,Strategic ,Partnership ,Ring ,Reading ,Ased ,Ointment ,United ,States ,Market ,